Literature DB >> 11423279

Fate of the aortic root after arterial switch operation.

P A Hutter1, B J Thomeer, P Jansen, J F Hitchcock, J A Faber, E J Meijboom, G B Bennink.   

Abstract

OBJECTIVE: Concerns have been voiced about possible dilation and insufficiency of the neo-aortic valve after the arterial switch operation (ASO). AIMS: To determine growth of the neo-aortic valve and the aortic anastomosis after ASO and the prevalence of insufficiency or stenosis. PATIENTS AND METHODS: Since 1977, 144 consecutive patients (pts) underwent ASO for transposition of the great arteries (TGA). Median follow-up was 8.65 years (0.1--22.5 years). Simple TGA was present in 97 pts and 47 had TGA with ventricular septal defect (VSD). Detailed echocardiography included measurements of aortic diameter at four levels. The 608 measurements were compared with published normal values.
RESULTS: The mean aortic valve z-score was 1.5, without significant change with age (P=0.75). Under 4 months, mean valve z-score was 0.63+/-2.20, between 5 and 12 months 2.56+/-2.30 (P<0.0001). Gradual growth occurs thereafter. The aortic sinus follows an identical growth pattern. The aorta at the anastomosis, is initially smaller than normal (z-score -0.64). After 4 months the z-score is 0.83, followed by continued growth of 0.1 z-score per year. At the last visit, the aortic valve z-score was above 2 in 51 patients, between -2 and 2 in 72 and less than -2 in six patients, none of whom had a flow velocity above 2 m/s. z-score of patients with VSD remained above those without VSD (P<0.0001). Aortic insufficiency was grade 2/4 in three patients, grade 3/4 in one and grade 4/4 in one. No patient developed aortic stenosis.
CONCLUSION: After ASO the neo-aortic valve and sinus are larger than normal, representing the natural size difference in the prenatal situation and influence of associated cardiac malformations. In the first year of life, rapid dilatation of the new aorta is observed, followed by growth towards normalization of the valve and sinus size. Stenosis at the anastomosis was not observed. Aortic dilatation by itself is rarely associated with significant insufficiency.

Entities:  

Mesh:

Year:  2001        PMID: 11423279     DOI: 10.1016/s1010-7940(01)00752-7

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Monitoring the patient with transposition of the great arteries: arterial switch versus atrial switch.

Authors:  Susan Lucy Roche; Candice Kristine Silversides; Erwin Notker Oechslin
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

2.  Risk factors for neo-aortic root enlargement and aortic regurgitation following arterial switch operation.

Authors:  C J McMahon; W J Ravekes; E O'Brian Smith; S W Denfield; R H Pignatelli; C A Altman; N A Ayres
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

3.  Valve-sparing aortic root replacement after neonatal arterial switch operation.

Authors:  Adishesh K Narahari; J Hunter Mehaffey; Michael Salerno; Robert Battle; Gorav Ailawadi
Journal:  J Card Surg       Date:  2021-02-27       Impact factor: 1.778

4.  Evaluation of cardiac and valvular function after arterial switch operation: a midterm follow-up.

Authors:  Hamid Amoozgar; Shirvan Salaminia; Ahmad Ali Amirghofran; Sirous Cheriki; Mohammad Borzoee; Gholamhossein Ajami; Farah Peiravian
Journal:  Int Cardiovasc Res J       Date:  2013-09-01

Review 5.  Aortopathy associated with congenital heart disease: A current literature review.

Authors:  Katrien Francois
Journal:  Ann Pediatr Cardiol       Date:  2015 Jan-Apr

6.  Progression of aortic root dilatation and aortic valve regurgitation after the arterial switch operation.

Authors:  Roel L F van der Palen; Teun van der Bom; Annika Dekker; Roula Tsonaka; Nan van Geloven; Irene M Kuipers; Thelma C Konings; Lukas A J Rammeloo; Arend D J Ten Harkel; Monique R M Jongbloed; Dave R Koolbergen; Barbara J M Mulder; Mark G Hazekamp; Nico A Blom
Journal:  Heart       Date:  2019-07-10       Impact factor: 5.994

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.